Market reports & researches
LOG IN | Services | Contact | Custom Research



Main Consumer Goods & Retail Personal care Medicated Skin Care in Ireland
Publications

(Currently 512486 Items)


Partners


Personal care / REPORT INFORMATION

Medicated Skin Care in Ireland

DateJul, 2006
Pages23
Price / format€700 / Electronic

€700 

Report Information | Custom-Tailored Research | Product Trade Lead


Abstract:
 Our Medicated Skin Care in Belgium report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (2000-2005), allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, distribution or pricing issues. Forecasts to 2010 illustrate how the market is set to change.

Product coverage: acne treatments, antipruritics, topical germicidals/antiseptics, topical allergy remedies/antihistamines, topical antifungals, vaginal antifungals, antiparasitics/lice (head and body) treatments, medicated shampoos, hair loss treatments, lip care treatments, haemorrhoid treatments, child-specific medicated skin care, nappy (diaper) rash treatments

Data coverage: market sizes (historic and forecasts), company shares and brand shares

Why buy this report?
- Get a detailed picture of the medicated skin care industry
- Identify factors driving change
- Understand the competitive environment, the market’s major players and leading brands
- Use five-year forecasts to assess how the market is predicted to develop

With a network of over 600 analysts worldwide we have a unique capability to develop reliable information resources to help drive informed strategic planning..





Ageing population and rising levels of self-medication to boost forecast performance
A number of positive factors are expected to help OTC healthcare growth in Ireland. A growing number of older people in the population, an increased tendency towards self-medication, a rethink of reimbursements and longer working hours will result in rising demand for products in all OTC healthcare sectors. The entry of private label products and a larger distribution share for non specialist channels will lead to a reduction in the unit prices of some products, which could limit the pace of constant value growth overall between 2004 and 2009.





Table of contents:
 1. EXECUTIVE SUMMARY

2. OPERATING ENVIRONMENT
- 2.1 OTC Healthcare Registration and Classification
- 2.2 Vitamins and Dietary Supplements Registration and Classification
- 2.3 Advertising
- 2.4 Packaging and Labelling
- 2.5 Distribution
- 2.6 De-listing or De-reimbursement
- 2.7 Traditional Remedies
- 2.8 Homeopathy
- 2.9 Generics
- 2.10 Consumer Expenditure on Health Goods and Medical Services
Table 1 Consumer Expenditure on Health Goods and Medical Services 1999-2004
- 2.11 Life Expectancy
Table 2 Life Expectancy at Birth 1999-2004

3. OTC HEALTHCARE SALES
- 3.1 Market Performance
Table 3 Sales of OTC Healthcare by Sector: Value 1999-2004
Table 4 Sales of OTC Healthcare by Sector: % Value Growth 1999-2004
- 3.2 Switches
- 3.3 Competitive Environment
Table 5 OTC Healthcare Company Shares 2001-2004
Table 6 OTC Healthcare Brand Shares 2001-2004
- 3.4 Leading Company Profiles – Crookes Healthcare Ltd
Summary 1 Crookes Healthcare Ltd Operational Indicators 2004
- 3.5 Leading Company Profiles – GlaxoSmithKline (Ireland)
Summary 2 GlaxoSmithKline (Ireland) Operational Indicators 2004
Summary 3 GlaxoSmithKline (Ireland): Production Statistics 2004
- 3.6 Leading Company Profiles – Pfizer Ireland Pharmaceuticals
Summary 4 Pfizer Ireland Pharmaceuticals Operational Indicators 2004
Summary 5 Pfizer Ireland Pharmaceuticals: Production Statistics 2004
- 3.7 Leading Company Profiles – Wyeth Consumer Healthcare
Summary 6 Wyeth Consumer Healthcare Ireland Ltd Operational Indicators 2004
Summary 7 Wyeth Consumer Healthcare: Production Statistics 2004
- 3.8 Retail Distribution
Table 7 Sales of OTC Healthcare by Distribution Format: % Analysis 1999/2004
Table 8 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2004
- 3.9 Retailer Activity and Private Label Trends
Table 9 Penetration of Private Label by Sector 2001-2004
- 3.10 Forecast Market Performance
Table 10 Forecast Sales of OTC Healthcare by Sector: Value 2004-2009
Table 11 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2004-2009

4. MEDICATED SKIN CARE SALES
- 4.1 Sector Performance
Table 12 Sales of Medicated Skin Care by Subsector: Value 1999-2004
Table 13 Sales of Medicated Skin Care by Subsector: % Value Growth 1999-2004
Table 14 Medicated Skin Care Company Shares 2001-2004
Table 15 Medicated Skin Care Brand Shares 2001-2004
Table 16 Forecast Sales of Medicated Skin Care by Subsector: Value 2004-2009
Table 17 Forecast Sales of Medicated Skin Care by Subsector: % Value Growth 2004-2009
Summary 8 Medicated Skin Care: New Product Launches 2004
- 4.2 Medicated Skin Care by Herbal/Standard Split
Table 18 Herbal vs Standard Medicated Skin Care 1999/2004
- 4.3 Acne Treatments Brand Shares
Table 19 Acne Treatments Brand Shares 2001-2004
- 4.4 Hair Loss Treatments Brand Shares
Table 20 Hair Loss Treatments Brand Shares 2001-2004

5. OTHER OTC

6. DEFINITIONS




Order this report

  Company name:
  Contact person:
  Phone/fax:
  Email:
  Comments:
   


Product Trade Lead
0 leads found


Add New Buy/Sell Lead

© 2007-2010 MarketReportFinder.com